Stalevo 150-37.5-200 mg is a combination medication formulated with three active ingredients: Carbidopa, Levodopa, and Entacapone, designed to effectively manage symptoms of Parkinson's disease. This medication works by increasing dopamine levels in the brain, which are often reduced in patients with Parkinson's. It is commonly used to replace previously taken separate doses of Carbidopa/Levodopa and Entacapone, ensuring improved efficiency and ease of use.
Key Features
- Combination therapy for effective treatment of Parkinson's disease.
- Contains Carbidopa 37.5 mg, Levodopa 150 mg, and Entacapone 200 mg.
- Formulated for enhanced absorption and effectiveness.
- 30 film-coated tablets for convenient daily use.
- Helps improve motor function and reduce symptoms.
- Prescription medication tailored for individual patient needs.
